top of page
Cat Portrait
Varenzin Logo.png

Introducing Varenzin™-CA1 (molidustat oral suspension), a groundbreaking advancement in feline healthcare. This innovative medication stands as the FIRST and ONLY FDA conditionally approved option specifically designed for the treatment of non-regenerative anemia in cats with chronic kidney disease (CKD). Varenzin™-CA1 is revolutionizing the standard of care, offering hope and relief to cats grappling with the debilitating effects of this often fatal condition.

Non-regenerative anemia, a common consequence of CKD in felines, has long posed a significant challenge in veterinary medicine. Varenzin™-CA1 addresses this concern with unparalleled efficacy, ushering in a new era of treatment possibilities. With its FDA conditional approval, this medication has proven its potential to make a substantial impact on the lives of cats and their devoted caregivers.

At Five Star Veterinary Center, we are honored to be at the forefront of this veterinary breakthrough, providing Varenzin™-CA1 to our valued clients. We understand the profound impact that feline companions have on our lives, and their well-being is our top priority. If you have any questions or would like more information about Varenzin™-CA1, please do not hesitate to reach out to us at (217) 241-2287. Your pet's health and happiness are of utmost importance to us, and we are here to support you every step of the way.

Click image below to learn more
bottom of page